Login / Signup

Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart.

Min ParkTakanori NishimuraCarlos D Baeza-GarzaStuart T CaldwellPamela Boon Li PunHiran A PragTim YoungOlga SauchankaAngela LoganMarleen ForkinkAnja V GruszczykTracy A PrimeSabine ArndtAlba NaudiReinald PamplonaMelinda T CoughlanMitchel TateRebecca H RitchieFederico CaicciNina KaludercicFabio Di LisaRobin A J SmithRichard C HartleyMichael P MurphyThomas Krieg
Published in: Cardiovascular drugs and therapy (2020)
Our work confirms that the Akita mouse model of diabetes replicates key clinical features of diabetic HFpEF, including cardiac and mitochondrial dysfunction. Furthermore, in this independent study, MitoGamide treatment improved diastolic function in Akita mice.
Keyphrases
  • type diabetes
  • mouse model
  • left ventricular
  • wound healing
  • cardiovascular disease
  • heart failure
  • blood pressure
  • glycemic control
  • atrial fibrillation
  • adipose tissue
  • metabolic syndrome
  • insulin resistance